A high-stakes power struggle has erupted between Pfizer Inc (NYSE:PFE) and activist investor Starboard Value, with Wall Street’s dealmaker, Alan Schwartz, and his firm, Guggenheim Partners, caught in the crossfire.
The activist investor had built a $1 billion stake in the U.S. drug maker. The…
